• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study.《癌症中美叶菀疗法的患者内省体验:一项定性研究》。
Integr Cancer Ther. 2023 Jan-Dec;22:15347354231198474. doi: 10.1177/15347354231198474.
2
Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.与乳腺癌患者接受补充槲寄生疗法相关的患者和社会方面:德国卫生技术评估机构委托进行的系统评价。
Eur J Oncol Nurs. 2023 Aug;65:102338. doi: 10.1016/j.ejon.2023.102338. Epub 2023 May 7.
3
Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.槲寄生制剂(欧洲槲寄生)用于癌症患者的疗效和安全性。一项系统评价。
Forsch Komplementmed. 2009 Aug;16(4):217-26. doi: 10.1159/000226249. Epub 2009 Jul 17.
4
[Mistletoe in the treatment of cancer patients].[槲寄生在癌症患者治疗中的应用]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):535-540. doi: 10.1007/s00103-020-03122-x.
5
Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.欧洲槲寄生(白果槲寄生)制剂瘤内应用在肿瘤学中的使用及安全性
Integr Cancer Ther. 2015 Mar;14(2):140-8. doi: 10.1177/1534735414563977. Epub 2014 Dec 30.
6
Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.化疗期间使用槲寄生提取物的辅助治疗:一项随机研究中的安全性、中性粒细胞减少、发热及生活质量评估
J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961. doi: 10.1089/acm.2018.0159.
7
Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.不可切除胰腺癌患者的瘤内槲寄生(欧洲槲寄生)治疗:一项回顾性分析
Integr Cancer Ther. 2014 Jul;13(4):332-40. doi: 10.1177/1534735413513637. Epub 2013 Dec 19.
8
[Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].[在原发性非转移性乳腺癌患者中,除传统肿瘤辅助治疗外,长期补充标准化欧洲槲寄生提取物(欧洲白槲寄生)的疗效和安全性。德国和瑞士多中心、对比性、流行病学队列研究结果]
Arzneimittelforschung. 2004;54(8):456-66. doi: 10.1055/s-0031-1296999.
9
The Subjective Dimension of Integrative Cancer Care: A Qualitative Study Exploring the Perspectives, Themes, and Observations of Experienced Doctors from the Area of Anthroposophic Medicine.《整体癌症护理的主观维度:一项探索经验丰富的人智医学领域医生的观点、主题和观察的定性研究》
Explore (NY). 2018 Sep;14(5):342-351. doi: 10.1016/j.explore.2018.03.007. Epub 2018 Aug 1.
10
Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.使用顺势疗法咨询综合肿瘤学诊所的乳腺癌患者的临床特征和治疗行为:登记数据分析。
BMC Complement Med Ther. 2023 Nov 3;23(1):395. doi: 10.1186/s12906-023-04219-x.

引用本文的文献

1
Mistletoe in Cancer Cell Biology: Recent Advances.槲寄生在癌细胞生物学中的研究进展
Curr Issues Mol Biol. 2025 Aug 20;47(8):672. doi: 10.3390/cimb47080672.

本文引用的文献

1
Cancer-related fatigue in patients treated with mistletoe extracts: a systematic review and meta-analysis.含槲寄生植物制剂治疗的癌症患者疲劳的系统评价和荟萃分析。
Support Care Cancer. 2022 Aug;30(8):6405-6418. doi: 10.1007/s00520-022-06921-x. Epub 2022 Mar 3.
2
Untargeted metabolomics approach to discriminate mistletoe commercial products.非靶向代谢组学方法鉴别槲寄生商业产品。
Sci Rep. 2021 Jul 9;11(1):14205. doi: 10.1038/s41598-021-93255-z.
3
Exploring the perceptions of cancer survivors of a mindfulness intervention at a tertiary hospital in Singapore: a descriptive qualitative study.探索新加坡一家三级医院正念干预对癌症幸存者认知的描述性定性研究。
Support Care Cancer. 2021 May;29(5):2723-2733. doi: 10.1007/s00520-020-05792-4. Epub 2020 Sep 26.
4
Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis.癌症患者接受槲寄生治疗的生活质量:系统评价和荟萃分析。
BMC Complement Med Ther. 2020 Jul 20;20(1):227. doi: 10.1186/s12906-020-03013-3.
5
A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings.一项关于使用发酵槲寄生提取物(Iscador)治疗癌症患者生存情况的系统评价和荟萃分析:研究结果的更新。
Complement Med Res. 2020;27(4):260-271. doi: 10.1159/000505202. Epub 2020 Jan 10.
6
A qualitative study of older adults' perspectives on initiating exercise and mindfulness practice.一项关于老年人对开始运动和正念练习的看法的定性研究。
BMC Geriatr. 2019 Dec 23;19(1):354. doi: 10.1186/s12877-019-1375-9.
7
Mindfulness-Based stress reduction in early palliative care for people with metastatic cancer: A mixed-method study.基于正念的早期姑息治疗对转移性癌症患者的压力缓解:一项混合方法研究。
Complement Ther Med. 2019 Dec;47:102218. doi: 10.1016/j.ctim.2019.102218. Epub 2019 Oct 19.
8
Editorial: The Challenges and Opportunities of Introspection in Psychology: Theory and Method.社论:心理学内省的挑战与机遇:理论与方法
Front Psychol. 2019 Oct 9;10:2196. doi: 10.3389/fpsyg.2019.02196. eCollection 2019.
9
The Myth of the Placebo Response.安慰剂反应的神话。
Front Psychiatry. 2019 Aug 16;10:577. doi: 10.3389/fpsyt.2019.00577. eCollection 2019.
10
Mistletoe and Immunomodulation: Insights and Implications for Anticancer Therapies.槲寄生与免疫调节:对抗癌疗法的见解与启示
Evid Based Complement Alternat Med. 2019 Apr 17;2019:5893017. doi: 10.1155/2019/5893017. eCollection 2019.

《癌症中美叶菀疗法的患者内省体验:一项定性研究》。

The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study.

机构信息

Witten/Herdecke University, Witten, Germany.

Society for Cancer Research, Arlesheim, Switzerland.

出版信息

Integr Cancer Ther. 2023 Jan-Dec;22:15347354231198474. doi: 10.1177/15347354231198474.

DOI:10.1177/15347354231198474
PMID:37731253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10515602/
Abstract

INTRODUCTION

The introspective experience of cancer patients using mistletoe therapy has received little scientific interest, although it is crucial for a holistic understanding of this therapy. This study contributes to patient-centered research and treatment by documenting the subjective experiences of individuals undergoing mistletoe therapy.

METHODS

In this qualitative, explorative study, 20 outpatients with a history of various cancer types were recruited from Arlesheim Hospital (Arlesheim, Switzerland). All patients received subcutaneous mistletoe therapy for at least 2 years (median 7.5 years). Data was collected through 2 semi-structured, in-depth interviews per patient. Qualitative content analysis was applied to examine the data. The individual experience of mistletoe therapy was analyzed in relation to 6 predefined levels of human experience: physical, vital, emotional, mental, spiritual and social. In addition, 3 further aspects, considered as cross-dimensional perspectives, emerged out of the material: warmth, immune strengthening, and general wellbeing.

RESULTS

Data analysis revealed considerable heterogeneity among patients' experiences with mistletoe therapy. The importance of specific aspects became apparent, such as increased vitality to manage daily life, greater emotional and mental stability, warmth as a multidimensional phenomenon, feelings of safety and protection through mistletoe therapy, heightened self-awareness and improved self-care, as well as sensations of spiritual connectedness.

CONCLUSIONS

Prior to this study it had not been shown that cancer patients using mistletoe therapy do have observations on different levels of experience. These results may lead to a deeper understanding of patients receiving mistletoe therapy, enabling them to be supported in a more holistic way both during mistletoe treatment and on their life path. Further investigations into the effects of mistletoe therapy on the emotional, mental, and spiritual level are warranted.

摘要

简介

癌症患者使用槲寄生疗法的内省体验很少引起科学界的兴趣,尽管这对于全面理解这种疗法至关重要。本研究通过记录接受槲寄生疗法的个体的主观体验,为以患者为中心的研究和治疗做出了贡献。

方法

在这项定性、探索性研究中,从瑞士阿尔莱希姆医院(Arlesheim,瑞士)招募了 20 名有多种癌症病史的门诊患者。所有患者均接受皮下槲寄生治疗至少 2 年(中位数 7.5 年)。通过对每位患者进行 2 次半结构化深入访谈来收集数据。采用定性内容分析法来检查数据。将个体接受槲寄生疗法的体验与人类体验的 6 个预设水平进行分析:身体、生命力、情感、心理、精神和社会。此外,从材料中还出现了 3 个被认为是跨维度的方面:温暖、增强免疫力和整体幸福感。

结果

数据分析显示,患者对槲寄生疗法的体验存在相当大的异质性。具体方面的重要性变得明显,例如增加活力以应对日常生活、增强情绪和心理稳定性、温暖作为一个多维现象、通过槲寄生疗法产生的安全感和保护感、自我意识的提高和自我保健的改善,以及精神联系的感觉。

结论

在这项研究之前,尚未证明使用槲寄生疗法的癌症患者确实对不同层面的体验有观察。这些结果可能会导致对接受槲寄生疗法的患者有更深入的了解,使他们在接受槲寄生治疗期间以及在他们的生活道路上能够得到更全面的支持。有必要进一步研究槲寄生疗法对情感、心理和精神层面的影响。